Ohno Receives NIH Grant

New York – Dr. Masuo Ohno, Project Investigator at the CDR, receives an R21 grant, titled “Synergy between BACE1 Inhibitors and Memantine for Alzheimer’s Disease Therapy.” The project will test the focused hypothesis that a combination of BACE1 inhibitors and memantine (an FDA-approved NMDA receptor antagonist drug) may complement each monotherapy to provide synergistic benefits and allow for lower doses of the individual drugs to avoid the side effect.